par Voit, Thomas;Topaloglu, Haluk;Straub, Volker;Muntoni, Francesco;Deconinck, Nicolas ;Campion, Giles;De Kimpe, Sjef J;Eagle, Michelle;Guglieri, Michela;Hood, Steve;Liefaard, Lia;Lourbakos, Afrodite;Morgan, Allison;Nakielny, Joanna;Quarcoo, Naashika;Ricotti, Valeria;Rolfe, Katie;Servais, Laurent;Wardell, Claire;Wilson, Rosamund ;Wright, Padraig;Kraus, John E
Référence Lancet neurology, 13, 10, page (987-996)
Publication Publié, 2014-10
Référence Lancet neurology, 13, 10, page (987-996)
Publication Publié, 2014-10
Article révisé par les pairs
Résumé : | Duchenne muscular dystrophy is caused by dystrophin deficiency and muscle deterioration and preferentially affects boys. Antisense-oligonucleotide-induced exon skipping allows synthesis of partially functional dystrophin. We investigated the efficacy and safety of drisapersen, a 2'-O-methyl-phosphorothioate antisense oligonucleotide, given for 48 weeks. |